₹ 378.91 Cr
2.4%
BSE Healthcare TRI
INF966L01CH1
5000.0
1000.0
1000
Mr. Sandeep Tandon
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Quant Healthcare Fund - IDCW Option - Regular Plan | -4.94 | - | - |
| Benchmark | - | - | - |
Equity
Debt
Others
The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. There is no assurance that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| TREPS 01-Dec-2025 DEPO 10 | 13.43 |
| Cipla Limited 30/12/2025 | 9.77 |
| SMS PHARMACEUTICALS LIMITED EQ NEW FV Re.1/- | 9.66 |
| SEQUENT SCIENTIFIC LIMITED EQ NEW FV RS. 2/- | 8.72 |
| ASTER DM HEALTHCARE LIMITED EQ | 7.85 |
| Zydus Wellness Ltd | 7.3 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 7.04 |
| PFIZER LIMITED EQ | 6.3 |
| GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/- | 5.85 |
| ADANI ENTERPRISES LIMITED EQ NEW FV RE.1/- | 5.72 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 63.74 |
| Fast Moving Consumer Goods | 7.3 |
| Metals & Mining | 5.85 |
| Realty | 2.63 |